Visiongain Publishes Track and Trace Solutions Market Report 2021-2031

08 December 2020
Pharma

Visiongain has published a new report on Track and Trace Solutions Market Report 2021-2031: Forecasts by Product (Plant Manager, Checkweighers, Barcode Scanner, Verification) Technology (2D Barcode, RFID) Application (Serialization, Aggregations, Reporting), End User (Pharmaceutical, Medical Devices). PLUS Profiles of Leading Track and Trace Product Manufacturing Companies and Regional and Leading National Market Analysis. PLUS COVID-19 Recovery Scenarios.

Global Track and Trace Solutions market was valued at US$ xx billion in 2020 and is projected to reach at a market value of US$ xx billion by 2031. The key factors driving the growth of this market include the severe regulations & principles for the implementation of serialization, increasing focus of manufacturers on brand protection, growth in the number of packaging-related product recalls, and growth in the medical device industry.

COVID-19 Impact on Track and Trace Solutions Market
The spread of COViD-19 pandemic has affected many industries globally. The track and trace market is predicted to boost during the forecast period owing to the need of tracking of COViD-19 patients at every hour at each corner of the globe. Thus, the track and trace solutions market will have a positive impact for its growth during the spread of pandemic.

Market Drivers
Growth in the medical device industry is driving the growth of the track and trace solutions market. The medical and pharmaceutical industry are adopting the tracking and tracing devices in order to be aware about the spread of novel diseases along with the data of patients who are getting in contact of the disease. The medical and hospital industry is also utilizing the advancement in technology provided by the track and trace solutions.

Market Opportunities
Remote authentication of products is increasing which is utilizing the tracking and tracing devices. Thus the industry involved in remote tracking and authenticating of medical and pharmaceutical devices are offering wide growth prospects for the track and trace solutions market.

Competitive Landscape
Some of the companies profiled in the report include OPTEL Group (Canada), Mettler-Toledo International Inc. (US), Systech International Inc. (US), TraceLink Inc. (US), Antares Vision (Italy), Xyntek Inc. (US), Adents International (France), SEA Vision Srl (Italy), Robert Bosch (Germany), Körber Medipak Systems AG (Switzerland), Siemens AG (Germany), Uhlmann Group (Germany), Zebra Technologies Corporation (US), Axway Inc. (US), and ACG Worldwide (India)

Recent Developments
• In 2018, Antares Vision introduced its product, ATSFOUR, an enterprise-level serialization software solution. The new ATSFOUR assimilates the Antares Tracking System architecture and offers a wide-ranging solution which allows the widest connection capability for any traceability network.
• In 2018, Ropack Pharma Solutions (Canada) signed a contract with Trace-Link (US) in order to achieve DSCSA compliance for its pharmaceutical customers.
• In 2017, OPTEL Group (Canada) bought Verify Brand LLC (US). The addition of Verify Brand’s L4/5 serialization capabilities to the OPTEL solution set enables the connectivity required for pharma companies to implement Track & Trace across the entire supply chain (L1 to L5).
• In 2017, Antares Vision joined hands with Xyntek, wherein Xyntek will continue to sell and service solutions of the Antares Tracking System platform throughout the US.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Dermatological Drugs Market Report 2021-2031

The global market for dermatological drugs is ascending and has made significant gains in skin treatments. The players in the dermatological drugs market are striving to tap the opportunities that this market offers.

18 January 2021

Read

Visiongain Publishes Antigen Skin Test Market Report to 2031

The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market. Increasing health concerns among population and growing incidences of fungal & bacterial infection are some of the factors driving the growth of Antigen Skin Test market.

12 January 2021

Read

Visiongain Publishes Top 50 Pharmaceutical Contract Manufacturing Organisations (CMOs) Market Report 2021

Fierce competition, stringent regulations, diminishing research and development, shrinking margins, strong price pressures and patent cliffs encompass today’s drug industry. It is a well-known fact that future of the pharmaceutical/biopharmaceutical industry depends on innovation, and innovation comes from collaborations or partnerships.

11 January 2021

Read

Visiongain Publishes Anti-Infective Vaccines Market Report Report to 2031

The study covers detailed and insightful chapters on market overview, market segments, new developments, competitive landscape, strategic recommendations, key company analysis, market opportunities, pricing analysis, gap analysis, porter’s 5 forces model, company profiling, geographical analysis, and analytical overview of the market.

11 January 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever